The Department of Immunobiochemistry at the Medical Faculty Mannheim of the Heidelberg University searches for a
PhD student (m/f/i) to work on a project in the framework of our DFG-funded research training group GRK2727: “Innate immune checkpoints in cancer and tissue damage”,
https://www.umm.uni-heidelberg.de/grk2727/, Twitter GRK2727: @grk2727
Activities and responsibilities
- Dissect regulatory mechanisms in NK cells and other innate lymphoid cells in newly generated cancer metastasis mouse models (e.g. by flow cytometry, single cell and spatial omics)
- Assess the importance of the microenvironment to shape NK/innate lymphoid cell responses
- Modulate the immune/cancer interface using immunotherapeutic interventions, such as checkpoint inhibitors or small molecular compounds
- Evaluate results with primary material from cancer patients and by data mining
- Benefit by a GRK2727 structured PhD educational program and international exchange with Stockholm and Vienna
Qualification profile
- University degree (master in e.g. biology, biochemistry or equivalent)
- In-depth knowledge of cellular and molecular biology and/or immunology
- High degree of motivation, enthusiasm for research, very good organizational skills
- Excellent English language and communication skills, interest in helping in graduate school organization
We offer
- Collaborations and lab-visits at the Karolinska Institute, Stockholm and Vienna University
- A versatile range of tasks, opportunity to learn and expand knowledge in immunology
- An open-minded, international and highly motivated team
- Support for combining family and career
- Support of your personal and career development by internal training programs of the Heidelberg University, mentoring within GRK2727
- Remuneration according to the provisions of the Civil Service Collective Agreement of the Federal States (TV-L)
- Pensions for the civil service (VBL)
We stand for equal opportunities. Severely disabled applicants with equal qualification will be given priority. For further information please contact Prof. Dr. Adelheid Cerwenka, (email) or Dr. Ana Stojanovic (email).